We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Gemini Bioproducts LLC, a supplier of cell culture solutions and a portfolio company of BelHealth Investment Partners, has launched the Moxi V for precision cell analysis.
Gemini Bioproducts LLC, a supplier of cell culture reagents and a portfolio company of BelHealth Investment Partners LLC, a New York-based healthcare private equity firm, has announced the opening of a new manufacturing facility in ...